Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein

David Bertwistle1, Frederique Zindy, Charles J Sherr

  • 1Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Hybridoma and Hybridomics
|January 28, 2005
PubMed

Insights

Researchers developed two monoclonal antibodies targeting mouse p19(Arf) protein. These antibodies effectively detect the Arf tumor suppressor in various assays and are useful for studying its role in mouse development and cancer.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The Arf tumor suppressor protein plays a crucial role in inhibiting cell proliferation via p53-dependent and -independent pathways.
  • Understanding Arf protein expression is vital for cancer research and developmental biology.

Purpose of the Study:

  • To develop and characterize novel monoclonal antibodies for detecting the mouse p19(Arf) protein.
  • To assess the utility of these antibodies in various immunological assays and for immunohistochemistry.

Main Methods:

  • Generation of rat monoclonal antibodies against a specific peptide of mouse p19(Arf).
  • Testing antibody reactivity with native p19(Arf) in mammalian cells.
  • Evaluation of antibody performance in immunoprecipitation, immunoblotting, and immunofluorescence assays.
  • Application of antibodies for immunohistochemical staining of fixed mouse tissues.

Main Results:

  • Two monoclonal antibodies (IgG2b isotype) were successfully raised against mouse p19(Arf) residues 54-62 and 62-75.
  • Antibodies demonstrated high efficiency in detecting native p19(Arf) via immunoprecipitation, immunoblotting, and immunofluorescence.
  • Neither antibody cross-reacted with human or golden hamster Arf proteins.
  • One antibody was effective for immunohistochemical staining of p19(Arf) in mouse spermatogonia nucleoli.

Conclusions:

  • The developed monoclonal antibodies are specific and efficient tools for detecting mouse p19(Arf).
  • These antibodies can be utilized to study endogenous p19(Arf) protein levels during mouse development and in early tumorigenesis.
  • The findings provide valuable reagents for cancer research and developmental studies involving the Arf pathway.